Health-related quality of life and treatment effects in patients with well-differentiated gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.

Elsa M RondeCharlotte M HeidsmaAnne M EskesJosefine E SchopmanElisabeth J M Nieveen van Dijkum

Published in: European journal of cancer care (2021)

All treatments appeared beneficial for disease stabilisation while maintaining stable global health status/QOL. High-quality HRQoL reporting was lacking. HRQoL should be a central outcome next to well-established outcomes.

Keyphrases

metabolic syndrome
combination therapy
adverse drug
neuroendocrine tumors
adipose tissue
skeletal muscle
electronic health record
smoking cessation
replacement therapy
glycemic control